Clinical trial
A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With…
NCT00140933 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00140933 |
|---|---|
| Title | A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome |
| Official title | A Randomized, Double-Blind, 7-Day Study of the Efficacy and Safety of Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | MK0966, rofecoxib, Comparator: diclofenac, placebo |
| Enrollment | 274 |
| Start date | Apr 1, 2003 |
| First posted | Sep 1, 2005 |
| Last update posted | Dec 5, 2006 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: